Following on from the highly successful World Vaccine Congress series in Washington DC and Europe for the past 18 years, the San Diego event will offer learning and business development opportunities taking advantage of the rich biotech and funding environment that the west coast offers.
The focus will be on the vaccines industry in general, but also more specifically on integrating the technologies revolutionising immunotherapy and its impact on vaccine development.
Over the course of the 2 day meeting in San Diego, all the sponsors and exhibitors will benefit from direct F2F access with over 250 vaccine focused delegates where in total there will be over 10 hours of networking sessions taking place.
Director, Vaccine Process Development, Merck
Director, Research & Development, Benchmark Research
Business Development and Marketing, Vibalogics GmbH
Senior Director, Sanofi Pasteur